… of long-term compliance with CPAP therapy, we reviewed our … prospective objective data on
CPAP use. The determinants of … CPAP therapy from baseline data and from computed CPAP …

… of CPAP use was 5.7 :':: 1.8 hours/day in OSA patients and 5.6 :':: 1.4 hours/day in snorers
who were still on CPAP … This study shows that CPAP therapy is reasonably accepted by OSA …

… the application of nasal CPAP to abolish obstructive apnea is associated with decreased
upper airway muscle activity. Consequently, therapeutic nasal CPAP does not improve upper …

… Although there are a number of therapeutic interventions that … (32, 54), the most effective
therapy is CPAP, which is usually … therapy in OSAS have particularly addressed CPAP therapy, …

… Since then, NCPAP has become the first-line therapy for patients with OSA because of … the
major problem with this therapy, 6 even in sleep apnea patients exhibiting daytime sleepiness…

… that oral-appliance therapy is indicated primarily for those with non severe obstructive
sleep apnea, we recommend that it be considered, alongside CPAP therapy, as treatment for …

… patients who adhere to nighttime CPAP therapy show significant improvement of their
quality of life, daytime sleepiness, and other symptoms after 6 months of treatment with CPAP. …

… In contrast, our data suggest that CPAP therapy improves measures of glucose tolerance
(although does not result in normalization of IGT) in patients with more severe sleep apnea …

… MSLTs in individuals with documented sleep apnea but an equivocal history for … CPAP
therapy in those patients who have a reduction in sleep-disordered breathing on nasal CPAP and …

… apneas. However, we do not believe that this accounts for differences in compliance …
CPAP because follow-up sleep studies demonstrated resolution of apneas with CPAP therapy …